The five-year framework agreement covers phased rollout of Lunit’s AI suite

South Korea-based Lunit, a leading provider of artificial intelligence (AI) for cancer diagnostics and therapeutics, has announced a strategic partnership with Starvision Service GmbH, Germany’s largest private radiology network.

 

Through a newly signed framework agreement, Lunit’s AI imaging solutions will be deployed across Starvision’s expansive network of radiological practices. Starvision operates 79 locations across seven German federal states, delivering services in radiology, nuclear medicine, and radiation therapy. As a recognized leader in the DACH healthcare market, Starvision is known for its commitment to digital transformation, operational excellence, and high-quality patient care.

 

Under the agreement, Starvision will adopt several of Lunit’s AI solutions, including:

The first commercial deployments are already underway—including use of Lunit INSIGHT MMG at Radiologische Allianz in Hamburg, supporting the Hamburg breast cancer screening program under the Starvision network.

 

Together with deployments at Die Radiologie, a major regional hospital group operating over 20 medical sites across Bavaria, Lunit’s solutions are now supporting approximately 120,000 breast cancer screenings and diagnoses annually across the two institutions.

 

The five-year framework agreement allows additional Starvision locations—and newly affiliated practices—to join at any time, enabling broad scalability across the network. New deployments and clinical trials are already in progress, with individual agreements being signed across Starvision’s entities as part of a phased implementation plan. Beyond Starvision, several other healthcare providers across Germany have also expressed interest, reflecting the expanding demand for AI-driven imaging solutions.